A recent breakthrough in the field of pharmaceutical research has seen significant gains thanks to an artificial intelligence (AI) tool called AWS GraphRAG. This cutting-edge technology enables researchers to accelerate their processes and significantly boost productivity, with one particular application seeing a dramatic reduction in cycle times.
Prior to the deployment of AWS GraphRAG, drug discovery cycles took over six months to complete, yielding a low success rate of just five percent. However, with this new solution, it's now possible to gather initial data and screen for potential compounds in a fraction of the time, paving the way for more rapid progress.
The real impact comes when considering the overall cycle duration, which has been dramatically reduced from six months to approximately 2-3 weeks. This represents a staggering increase of nearly three-quarters over the original timeframe, marking a major milestone in the pharmaceutical industry's pursuit of faster and more effective drug development.